Drugs Health

Fetus treated with risdiplam for rare genetic disorder, a medical first

HQ Team February 27, 2025: A study published in The New England Journal of Medicine (NEJM) reveals that administration of the oral drug.

Read More
Drugs Medical Pharma

Eli Lilly to set up four manufacturing facilities in US for $27 billion

Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according.

Read More
Drugs Health Medical

WHO Foundation to crowdsource funds for global health programmes

The World Health Organization is crowdsourcing to fund its health programs by urging individuals globally to donate to the ‘1 Dollar 1 World.

Read More
Drugs Health Pharma

AstraZeneca says trial breast cancer drug improves survival rates

AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the.

Read More
Drugs Health Medical

Unknown illness sweeps across Congo’s northwest, 53 people die

A mystery illness sweeping over Congo has killed 53 people and infected 400 more, with an initial probe tracking the outbreak to three.

Read More
Drugs Health Pharma

Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats

Eli Lilly and Company cut the prices of its weight-loss drug  Zepbound, available in single-dose vials, in a bid to end compounding companies from.

Read More
Drugs Health Medical

Regeneron’s trial therapy improves hearing in children with gene mutations

Regeneron Pharmaceuticals, Inc.’s investigational gene therapy improved hearing in 10 out of 11 children born with hearing loss because of gene mutation, according.

Read More
Drugs Health Pharma

Breast cancer death rates globally to rise 68% by 2050: WHO arm IARC warns

Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.

Read More
Drugs Health Medical

US regulator clears Mirum’s oral drug for reducing cholesterol deposits

Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.

Read More
Drugs Health

Artificial sweeteners spike insulin levels, increasing risk of heart diseases

HQ Team February 21, 2025: Artificial sweeteners, long used as low-calorie alternatives to sugar, are known to cause a number of health conditions,.

Read More